← Human Trials & Peer-Reviewed Studies
[Hormonal premedication in endometrium ablation--results of a prospective comparative study]
Plain-language guide to PMID 8701626 (1996): randomized controlled trial study of Triptorelin in 40 patients, endometriosis.
Key Facts
- PMID
- 8701626
- Journal
- Zentralblatt fur Gynakologie
- Year
- 1996
- Study type
- Randomized Controlled Trial
- Authors
- Römer T et al. (5 authors)
What This Study Did, in Plain Language
What Was Tested
Researchers studied Triptorelin in the context of endometriosis in this randomized controlled trial publication.
Who Took Part
The study group was 40 patients.
The age groups tagged for this paper are adults and middle-aged adults, women only.
How the Study Was Run
The researchers set it up as a randomized study.
The patients were allocated by chance, so the Triptorelin group and the comparison group should start out alike.
What Was Measured
The subject headings attached to it are Biopsy, Combined Modality Therapy, Danazol, Endometrium, Estrogen Antagonists, Luteolytic Agents and Lynestrenol.
What This Means in Plain Language
The paper is a randomized study of Triptorelin in 40 patients in people with endometriosis.
The publication is from 1996 (Zentralblatt fur Gynakologie), a journal based in Germany.
More context: the Triptorelin compound page, Endometriosis research.
Our Notes on the Compound
Triptorelin: A 10-amino-acid GnRH analog (Trelstar, Decapeptyl, Triptodur) used in prostate cancer, early puberty and fertility protocols.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.